CTOs on the Move

Kedrion

www.kedrion.com

 
Kedrion Biopharma develops and produces plasma-derived therapies, making them available to meet patients` needs the world over. We collect and fractionate blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies. A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion`s business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.kedrion.com
  • 400 Kelby St Fl 11
    Fort Lee, NJ USA 07024
  • Phone: 201.242.8900

Executives

Name Title Contact Details

Similar Companies

Morristown Manor

Morristown Manor is a Morristown, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phoenix Associates

Phoenix Associates is a Mount Holly, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St Paul and Area Food Bank

St Paul and Area Food Bank is a St Paul, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.

Tufts Health Care Institute

Tufts Health Care Institute is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.